Innovation

Clip 5 of 5 from: The Biodesign Innovation Process [Entire Talk]

Clip 5 of 5

Josh Makower, MD, Stanford Byers Center for Biodesign

Success and Failure in the Biodesign Process

Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.

Clip 3 of 5 from: The Biodesign Innovation Process [Entire Talk]

Clip 3 of 5

Josh Makower, MD, Stanford Byers Center for Biodesign

Solutions for Rare Conditions

Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.

Clip 4 of 5 from: The Biodesign Innovation Process [Entire Talk]

Clip 4 of 5

Josh Makower, MD, Stanford Byers Center for Biodesign

Innovating for Health Equity

Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.

Clip 2 of 5 from: The Biodesign Innovation Process [Entire Talk]

Clip 2 of 5

Josh Makower, MD, Stanford Byers Center for Biodesign

Medical Innovation and Profit

Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.

Biotech offers huge rewards for founders who approach risk strategically.

Derisking Biotech [Entire Talk]

Video 53 minutes

Kristen Fortney, BioAge Labs

Derisking Biotech [Entire Talk]

Biotech offers huge rewards for founders who approach risk strategically.

Video Clips

3 minutes
Derisking Milestones in Biotech
2 minutes
Bringing New Biotech Treatments to Market
2 minutes
Opportunities in Aging and Biotech

Biotech offers huge rewards for founders who approach risk strategically.

Derisking Biotech

Podcast 53 minutes

Clip 3 of 3

Clip 3 of 3 from: Derisking Biotech [Entire Talk]

Biotech offers huge rewards for founders who approach risk strategically.

Opportunities in Aging and Biotech

Clip 1 of 3 from: Derisking Biotech [Entire Talk]

Clip 1 of 3

Biotech offers huge rewards for founders who approach risk strategically.

Derisking Milestones in Biotech

Clip 2 of 3 from: Derisking Biotech [Entire Talk]

Clip 2 of 3

Biotech offers huge rewards for founders who approach risk strategically.

Bringing New Biotech Treatments to Market

Discover new opportunities by thinking beyond borders.

Jorge Rios, Bridgefy

Seizing Global Opportunities

Podcast 58 minutes

Russ Altman, Stanford University Kim Branson, GSK

Principled Engineering: AI and Drug Development [Entire Talk]

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Video 58 minutes

Russ Altman, Stanford University Kim Branson, GSK

Principled Engineering: AI and Drug Development [Entire Talk]

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Video Clips

3 minutes
Ethical Guardrails for AI in Drug Development
3 minutes
Ethical Science is Better Science
9 minutes
Innovation-Driven Engagement with Regulators
3 minutes
Where is AI-Driven Bioengineering Headed Next?

Russ Altman, Stanford University Kim Branson, GSK

Principled Engineering: AI and Drug Development

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Podcast 59 minutes

Clip 1 of 4

Clip 1 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk]

Russ Altman, Stanford University Kim Branson, GSK

Ethical Guardrails for AI in Drug Development

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Clip 2 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk]

Clip 2 of 4

Russ Altman, Stanford University Kim Branson, GSK

Ethical Science is Better Science

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Clip 4 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk]

Clip 4 of 4

Russ Altman, Stanford University Kim Branson, GSK

Where is AI-Driven Bioengineering Headed Next?

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Clip 3 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk]

Clip 3 of 4

Russ Altman, Stanford University Kim Branson, GSK

Innovation-Driven Engagement with Regulators

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Video Clip 9 minutes

Driving innovation in government and physical infrastructure can be difficult — and rewarding.

Solving for Infrastructure [Entire Talk]

Video 56 minutes

Paola Santana, GLASS

Solving for Infrastructure [Entire Talk]

Driving innovation in government and physical infrastructure can be difficult — and rewarding.

Video Clips

5 minutes
Do the Work, then Talk About It
8 minutes
Think About the End at the Beginning
5 minutes
Why Govtech?
5 minutes
Being a Latina Founder in Tech
2 minutes
How to Build Productive Relationships with Regulators

Governments might be the largest market that Silicon Valley hasn’t cracked.

Solving for Infrastructure

Podcast 57 minutes

Clip 5 of 5

Clip 5 of 5 from: Solving for Infrastructure [Entire Talk]

Driving innovation in government and physical infrastructure can be difficult — and rewarding.

How to Build Productive Relationships with Regulators

Clip 2 of 5 from: Solving for Infrastructure [Entire Talk]

Clip 2 of 5

Driving innovation in government and physical infrastructure can be difficult — and rewarding.

Think About the End at the Beginning

Video Clip 8 minutes

Clip 4 of 5

Clip 4 of 5 from: Solving for Infrastructure [Entire Talk]